Back
By:Dr. Menghis Bairu
Date:February 09, 2024
A major step towards providing safe, effective and affordable biologics in Africa and beyond.
KIGALI, RWANDA AND SAN FRANCISCO, CALIFORNIA—FEB 9, 2024—
Bio Usawa Biotechnology Ltd announced that it has, in cooperation with the Rwanda Development Board, established its first subsidiary in Africa. This is aligned with Bio Usawa’ s vision of making Africa a manufacturing powerhouse and exporter of high-quality and affordable biologics. Bio Usawa shares the vision of African nations towards affordable, equitable healthcare that will have significant impact on human lives.
Dr. Bairu, CEO and co-founder of Bio Usawa, remarked, “the Bio Usawa team would like to express its appreciation for the rapid registration of Biousawa’ s accessory organization in Rwanda and applauds its collaboration with the Rwanda Development Board, its partners, and citizens of Rwanda for providing safe, effective and affordable biologics for people in Africa and beyond."
Dr Menghis Bairu, and TWIN Global member recently met Mr. Francis Gatare, Cabinet Member and CEO, Rwanda Development Board (RDB). Dr Gatare provided an overview of the Rwanda Development Board’s vision and priorities.
Dr Bairu shared Bio Usawa’ s vision of manufacturing quality lifesaving biologics for cancer, immunology, and ophthalmology in Africa, by Africans, for African and beyond. Biousawa is also committed to developing and strengthening R&D capacities in Rwanda and other African nations by augmenting biologics research, manufacturing of biologics, strict quality control and by focusing on the solutions reaching the last mile through an equitable distribution supply chain system. Dr Menghis also discussed Bio Usawa’ s collaborations with the Rwanda Development Board for technology transfer and capacity building for end-to-end biologics development.
With the vision of transforming into a dynamic global hub for business, investment and innovation, the Rwanda Development Board, a premier institution of the Government of Rwanda, has established the Special Economic Zone (SEZ) and 9 Industrial parks in the country. The SEZ and the industrial park hub is designed to accelerate the supply of locally manufactured medical products including drugs, vaccines, and technologies to the domestic and global population. In addition, Rwanda has established a robust market access to African and global nations through well-structured free trade agreements.
Resources:
Manufacturing - Official Rwanda Development Board (RDB) Website
Bio Usawa Inc. | Home
Bio Usawa Inc cofounder grateful to have been a part of the prestigious African Organization for Research & Training in Cancer (APRTIC) Conference, in D…
Nov 2023It was a distinct pleasure to meet with the leadership of the prestigious Institute and tour the facility. Bio Usawa and IPD share a common goal of d…
Nov 2023Humbled and honored to have had the opportunity to discuss Bio Usawa’s vision with highly accomplished hematologists and oncologists at the wel…
Dec 2023Dr. Menghis Bairu, co-founder and CEO of Biousawa Biotechnology Ltd in a meeting with Mr. Francis Gatare, CEO, #RwandaDevelopment Board shared the compa…
Feb 2024It was such an honor for our TWIN group delegation to visit Dr Sabin Nsanzimana, Minister of Health, #Rwanda. I shared briefly our Rwanda based #BioUsaw…
Feb 2024Most people know Oliver Wendell Holmes Sr., the father of the Supreme Court Justice Oliver Wendell Holmes Jr., as a poet and a writer. Along with Lon…
Feb 2024Monoclonal Antibodies for Malaria
Malaria is a devastating disease. It was the cause of 627,000 deaths worldwide in 2020, and malaria-related…
Feb 2024BIO USAWA INC. is pleased to announce its participation in the prestigious African Diaspora Network Forum, scheduled to occur from March 20th to 22nd 20…
Mar 2024In a landmark move for global healthcare, Bio Usawa Inc., a pioneering African manufacturer of monoclonal antibodies (MAB), commends the United States g…
Apr 2024Bio Usawa Inc. team led by Dr. Menghis Bairu, Co-founder, CEO and President, John Hautman Bio Usawa Chief Legal officer and Bio Usawa Consultant Carolyn…
Feb 2024As one of its earliest hires, Vince Anicetti had a 30-year career at Genentech, the premier company in the manufacturing of monoclonal antibodies, where…
Apr 2024“Our mission at Bio Usawa is to ensure that no African patient is denied access to essential therapies due to financial constraints,” stated Dr. Bairu. …
Apr 2024In the race towards Universal Health Coverage (UHC) in Africa, the integration of biosimilars, particularly monoclonal antibodies (MABs), stands out as …
Apr 2024Attending the upcoming Lagos, Nigeria May 7-9, 2024 Industry Engagement Forum themed “Unlocking Healthcare Value Chains and Driving Investment through P…
May 2024The African diaspora's role in the continent's socioeconomic transformation can no longer be overlooked. As we delve deeper into the 21st century, it be…
May 2024Bio Usawa Inc. (BUI) is excited to welcome Raj Shankar Ghosh as Chief Innovation and Strategy Officer to its leadership team. With over three and a half…
Jun 2024As the global population ages, Alzheimer's disease (AD) emerges as a chief concern for health systems and increasingly as a mirror reflecting the deep i…
Jun 2024